SS
Sanjay Shukla
President and CEO

Sanjay Shukla insider trades: aTYR PHARMA (ATYR) stock buys and sales

President and CEO, aTYR PHARMA Last trade Feb 4, 2026 30 Form 4 filings
$4K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2020
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sanjay reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 4, 2026ATYR↓ Sell$4K
May 31, 2024LIFE↑ Buy$36K
Dec 12, 2023LIFE↑ Buy$18K
Nov 13, 2023LIFE↑ Buy$17K
Jul 28, 2023LIFE↑ Buy$30K
Nov 21, 2022LIFE↑ Buy$21K
Jul 1, 2022LIFE↑ Buy$43K
Jan 7, 2022LIFE↑ Buy$34K
Nov 15, 2021LIFE↑ Buy$21K
May 18, 2021LIFE↑ Buy$40K
Feb 9, 2021LIFE↓ Sell$6K
Jun 19, 2020LIFE↑ Buy$26K
Feb 7, 2020LIFE↓ Sell$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ATYR insiders

Open-market trades in the last 12 months

About Sanjay Shukla's insider trades

Sanjay Shukla is President and CEO at aTYR PHARMA (ATYR). Since Feb 7, 2020, Sanjay has reported 10 open-market purchases worth $286K and 3 sales worth $13K on SEC Form 4. In the last 12 months: 1 sale ($4K).

Their filings also include grants and awards (15 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATYR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.